An Open-Label, Non-Comparative, Multi-Centre, Phase II Prospective Trial to Assess the Efficacy of Quetiapine Fumarate Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) in SSRI-Resistant Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2008
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms UNIQUE
- Sponsors AstraZeneca
- 05 Sep 2008 New trial record.